Cizzle Biotech received its initial funding from various sources including Yorkshire Cancer Research, White Rose Technology Seed Corn Fund, Finance Yorkshire Seedcorn LLP and Viking Members. The funds were invested in the project to aid the development of a prototype blood test, with the support of the management team.